bmd mics Search Results


daptomycin and vancomycin clsi7 broth microdilution (bmd) mics  (Becton Dickinson)
90
Becton Dickinson daptomycin and vancomycin clsi7 broth microdilution (bmd) mics
Daptomycin And Vancomycin Clsi7 Broth Microdilution (Bmd) Mics, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmd+mics/pm21393156-21-0-20?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
daptomycin and vancomycin clsi7 broth microdilution (bmd) mics - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
bmd mics  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute bmd mics
BPH0662 - a clinically significant, multidrug-resistant S. epidermidis. (a) Summary of case patient’s clinical course. (b) Magnetic resonance imaging (MRI) slices of the patient’s brain, demonstrating a large cerebral abscess (red arrow) formed around the tip of an external ventricular drain (EVD) device (yellow arrow). (c) Vancomycin population analysis profile of three S. epidermidis isolates from the case patient compared with reference strains Mu3 [heterogeneous vancomycin intermediate S. aureus (hVISA)] and Mu50 [vancomycin intermediate S. aureus (VISA)]. (d) Correlation of phenotypic susceptibility testing for case patient isolates with the BPH0662 resistome. L, left; R, right; VP, ventriculoperitoneal; CSF, cerebrospinal fluid; PEN, penicillin; FLX, flucloxacillin; COT, cotrimixazole; GEN, gentamicin; CIP, ciprofloxacin; ERY, erythromycin; CLI, clindamycin; FA, fusidic acid; RIF, rifampicin; TEC, tecoplanin; VAN, vancomycin; DAP, daptomycin; TET, tetracycline; LZD, linezolid; <t>BMD,</t> broth microdilution; MET, macromethod Etest; PAP/AUC, population analysis profile/ area under the curve (compared with Mu3 hVISA reference).
Bmd Mics, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmd+mics/pmc05537629-96-0-12?v=Clinical+and+Laboratory+Standards+Institute
Average 90 stars, based on 1 article reviews
bmd mics - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
clsi bmd mics  (Innovotech inc)
90
Innovotech inc clsi bmd mics
BPH0662 - a clinically significant, multidrug-resistant S. epidermidis. (a) Summary of case patient’s clinical course. (b) Magnetic resonance imaging (MRI) slices of the patient’s brain, demonstrating a large cerebral abscess (red arrow) formed around the tip of an external ventricular drain (EVD) device (yellow arrow). (c) Vancomycin population analysis profile of three S. epidermidis isolates from the case patient compared with reference strains Mu3 [heterogeneous vancomycin intermediate S. aureus (hVISA)] and Mu50 [vancomycin intermediate S. aureus (VISA)]. (d) Correlation of phenotypic susceptibility testing for case patient isolates with the BPH0662 resistome. L, left; R, right; VP, ventriculoperitoneal; CSF, cerebrospinal fluid; PEN, penicillin; FLX, flucloxacillin; COT, cotrimixazole; GEN, gentamicin; CIP, ciprofloxacin; ERY, erythromycin; CLI, clindamycin; FA, fusidic acid; RIF, rifampicin; TEC, tecoplanin; VAN, vancomycin; DAP, daptomycin; TET, tetracycline; LZD, linezolid; <t>BMD,</t> broth microdilution; MET, macromethod Etest; PAP/AUC, population analysis profile/ area under the curve (compared with Mu3 hVISA reference).
Clsi Bmd Mics, supplied by Innovotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmd+mics/pmc02542894-159-0-4?v=Innovotech+inc
Average 90 stars, based on 1 article reviews
clsi bmd mics - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


BPH0662 - a clinically significant, multidrug-resistant S. epidermidis. (a) Summary of case patient’s clinical course. (b) Magnetic resonance imaging (MRI) slices of the patient’s brain, demonstrating a large cerebral abscess (red arrow) formed around the tip of an external ventricular drain (EVD) device (yellow arrow). (c) Vancomycin population analysis profile of three S. epidermidis isolates from the case patient compared with reference strains Mu3 [heterogeneous vancomycin intermediate S. aureus (hVISA)] and Mu50 [vancomycin intermediate S. aureus (VISA)]. (d) Correlation of phenotypic susceptibility testing for case patient isolates with the BPH0662 resistome. L, left; R, right; VP, ventriculoperitoneal; CSF, cerebrospinal fluid; PEN, penicillin; FLX, flucloxacillin; COT, cotrimixazole; GEN, gentamicin; CIP, ciprofloxacin; ERY, erythromycin; CLI, clindamycin; FA, fusidic acid; RIF, rifampicin; TEC, tecoplanin; VAN, vancomycin; DAP, daptomycin; TET, tetracycline; LZD, linezolid; BMD, broth microdilution; MET, macromethod Etest; PAP/AUC, population analysis profile/ area under the curve (compared with Mu3 hVISA reference).

Journal: Microbial Genomics

Article Title: Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis

doi: 10.1099/mgen.0.000077

Figure Lengend Snippet: BPH0662 - a clinically significant, multidrug-resistant S. epidermidis. (a) Summary of case patient’s clinical course. (b) Magnetic resonance imaging (MRI) slices of the patient’s brain, demonstrating a large cerebral abscess (red arrow) formed around the tip of an external ventricular drain (EVD) device (yellow arrow). (c) Vancomycin population analysis profile of three S. epidermidis isolates from the case patient compared with reference strains Mu3 [heterogeneous vancomycin intermediate S. aureus (hVISA)] and Mu50 [vancomycin intermediate S. aureus (VISA)]. (d) Correlation of phenotypic susceptibility testing for case patient isolates with the BPH0662 resistome. L, left; R, right; VP, ventriculoperitoneal; CSF, cerebrospinal fluid; PEN, penicillin; FLX, flucloxacillin; COT, cotrimixazole; GEN, gentamicin; CIP, ciprofloxacin; ERY, erythromycin; CLI, clindamycin; FA, fusidic acid; RIF, rifampicin; TEC, tecoplanin; VAN, vancomycin; DAP, daptomycin; TET, tetracycline; LZD, linezolid; BMD, broth microdilution; MET, macromethod Etest; PAP/AUC, population analysis profile/ area under the curve (compared with Mu3 hVISA reference).

Article Snippet: BMD MICs for vancomycin and rifampicin were determined as recommended by the Clinical and Laboratory Standards Institute ( ).

Techniques: Magnetic Resonance Imaging